糖心vlog

[Skip to Navigation]
Sign In

October 2024 - April 2016

Decade

Year

Issue

July 2023, Vol 8, No. 7, Pages 628-710

Original Investigation

Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):631-639. doi:10.1001/jamacardio.2023.1177

This pooled analysis includes data from 4 major randomized clinical trials that compare PCI with drug-eluting stents vs CABG to assess differences in outcomes for patients with left main coronary artery disease with and without acute coronary syndrome.

Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial

Abstract Full Text
open access
JAMA Cardiol. 2023;8(7):640-649. doi:10.1001/jamacardio.2023.1090

This post hoc analysis of a randomized clinical trial evaluates the safety and efficacy of empagliflozin in patients with heart failure and preserved ejection fraction who are taking diuretics.

Contemporary Use of Sodium-Glucose Cotransporter-2 Inhibitor Therapy Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction in the US: The Get With The Guidelines鈥揌eart Failure Registry

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):652-661. doi:10.1001/jamacardio.2023.1266

This cohort study characterizes patterns of sodium-glucose cotransporter-2 inhibitor use among eligible patients hospitalized for heart failure with reduced ejection fraction (HFrEF).

Diagnostic and Prognostic Value of Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):662-673. doi:10.1001/jamacardio.2023.1290

This systematic review and meta-analysis assesses the diagnostic accuracy and prognostic value of stress cardiovascular magnetic resonance imaging in patients with stable chest pain and known or suspected coronary artery disease.

Genetic Risk Factors Associated With Preeclampsia and Hypertensive Disorders of Pregnancy

Abstract Full Text
open access
JAMA Cardiol. 2023;8(7):674-683. doi:10.1001/jamacardio.2023.1312

This genome-wide association study seeks to identify genetic risk factors associated with preeclampsia and hypertensive disorders in pregnancy.

Brief Report

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial

Abstract Full Text
open access
JAMA Cardiol. 2023;8(7):684-690. doi:10.1001/jamacardio.2023.1342

This secondary analysis of a randomized clinical trial evaluates the association between treatment with dapagliflozin vs placebo and improvement in components of the Kansas City Cardiomyopathy Questionnaire.

Heterogeneity of Lipoprotein(a) Levels Among Hispanic or Latino Individuals Residing in the US

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):691-696. doi:10.1001/jamacardio.2023.1134

This cohort study investigates the distribution of lipoprotein(a) levels among Hispanic or Latino individuals residing in the US.

Association of Circulating Cardiomyocyte Cell-Free DNA With Cancer Therapy鈥揜elated Cardiac Dysfunction in Patients Undergoing Treatment for ERBB2-Positive Breast Cancer

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):697-702. doi:10.1001/jamacardio.2023.1229

This cohort study analyzes biomarker data for patients with ERBB2-positive breast cancer to determine the association between circulating cardiomyocyte cell-free DNA and subsequent cancer therapy鈥搑elated cardiac dysfunction after anthracycline chemotherapy and ERBB2-targeted therapy.

Titanium-Nitride-Oxide鈥揅oated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):703-708. doi:10.1001/jamacardio.2023.1373

This randomized clinical trial compares the rate of main composite outcome of cardiac death, myocardial infarction, or ischemia-driven target lesion revascularization at 5 years in patients with acute coronary syndromes.

Viewpoint

The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw鈥擲tating What Should Be Obvious

Abstract Full Text
JAMA Cardiol. 2023;8(7):629-630. doi:10.1001/jamacardio.2023.1287

This Viewpoint describes the advantages of measuring a lipid panel before cardiac catheterization to optimize lipid-lowering therapy.

Invited Commentary
Cardiovascular Images

A Man Aged 45 Years With Chinese Dragon Sign on Chest Radiography

Abstract Full Text
has active quiz
JAMA Cardiol. 2023;8(7):709. doi:10.1001/jamacardio.2023.1104

This case report discusses a diagnosis of acute systolic heart failure in a man aged 45 years with multiple radiographic findings, including the Chinese dragon sign.

Comment & Response

Explanation of Error in the Clinical Challenge, 鈥淎 Case of Right Bundle Branch Block With Changing Axis鈥

Abstract Full Text
JAMA Cardiol. 2023;8(7):710. doi:10.1001/jamacardio.2023.1119
Editor's Note

When Is a High Lipoprotein (a) Concentration Too High?鈥擳he Need for Diverse Population-Based Samples

Abstract Full Text
JAMA Cardiol. 2023;8(7):696. doi:10.1001/jamacardio.2023.1141
Correction

Error in Figure

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):710. doi:10.1001/jamacardio.2023.1358

Error in Diagnosis and Text

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):710. doi:10.1001/jamacardio.2023.1410
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2023;8(7):628. doi:10.1001/jamacardio.2022.3444
×